A database to support the interpretation of human mismatch repair gene variants

Germline mutations in the mismatch repair (MMR) genes MLH1, MSH2, MSH6, or PMS2 can cause Lynch syndrome. This syndrome, also known as hereditary nonpolyposis colorectal cancer (HNPCC), is an autosomal dominantly‐inherited disorder predominantly characterized by colorectal and endometrial cancer. Truncating MMR gene mutations generally offer a clear handle for genetic counseling and allow for presymptomatic testing. In contrast, the clinical implications of most missense mutations and small in‐frame deletions detected in patients suspected of having Lynch syndrome are unclear. We have constructed an online database, the Mismatch Repair Gene Unclassified Variants Database (www.mmruv.info), for information on the results of functional assays and other findings that may help in classifying these MMR gene variants. Ideally, such mutations should be clinically classified by a broad expert panel rather than by the individual database curators. In addition, the different MMR gene mutation databases could be interlinked or combined to increase user‐friendliness and avoid unnecessary overlap between them. Both activities are presently being organized by the International Society for Gastrointestinal Hereditary Tumours (InSiGHT; www.insight‐group.org). Hum Mutat 29(11), 1337–1341, 2008. © 2008 Wiley‐Liss, Inc.

[1]  A. Spurdle,et al.  Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results , 2008, Human mutation.

[2]  P. Stenson,et al.  Human Gene Mutation Database: towards a comprehensive central mutation database , 2007, Journal of Medical Genetics.

[3]  A. Spurdle,et al.  Locus‐specific databases and recommendations to strengthen their contribution to the classification of variants in cancer susceptibility genes , 2008, Human mutation.

[4]  C. Boland,et al.  Phenotypic and genotypic heterogeneity in the Lynch syndrome: diagnostic, surveillance and management implications , 2006, European Journal of Human Genetics.

[5]  M. Nyström,et al.  The first functional study of MLH3 mutations found in cancer patients , 2008, Genes, chromosomes & cancer.

[6]  P. Peltomäki,et al.  Mutations Associated with HNPCC Predisposition — Update of ICG-HNPCC/INSiGHT Mutation Database , 2004, Disease markers.

[7]  Fergus J Couch,et al.  A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes. , 2007, American journal of human genetics.

[8]  N. de Wind,et al.  Tumor characteristics as an analytic tool for classifying genetic variants of uncertain clinical significance , 2008, Human mutation.

[9]  F. Couch,et al.  Identification of BRCA1 missense substitutions that confer partial functional activity: potential moderate risk variants? , 2007, Breast Cancer Research.

[10]  Qing Wang,et al.  Systematic mRNA analysis for the effect of MLH1 and MSH2 missense and silent mutations on aberrant splicing , 2006, Human mutation.

[11]  I. Fokkema,et al.  LOVD: Easy creation of a locus‐specific sequence variation database using an “LSDB‐in‐a‐box” approach , 2005, Human mutation.

[12]  H. Campbell,et al.  Classification of ambiguous mutations in DNA mismatch repair genes identified in a population‐based study of colorectal cancer , 2008, Human mutation.

[13]  Michael O Woods,et al.  A new variant database for mismatch repair genes associated with Lynch syndrome , 2007, Human mutation.

[14]  S. Tavtigian,et al.  In silico analysis of missense substitutions using sequence‐alignment based methods , 2008, Human mutation.

[15]  R. Cotton.  Recommendations of the 2006 Human Variome Project meeting , 2007, Nature Genetics.

[16]  N. de Wind,et al.  Functional analysis helps to clarify the clinical importance of unclassified variants in DNA mismatch repair genes , 2007, Human mutation.

[17]  H. Hollema,et al.  A role for MLH3 in hereditary nonpolyposis colorectal cancer , 2001, Nature Genetics.

[18]  F. Couch,et al.  Assessment of functional effects of unclassified genetic variants , 2008, Human mutation.

[19]  Douglas F Easton,et al.  Genetic evidence and integration of various data sources for classifying uncertain variants into a single model , 2008, Human mutation.

[20]  Andrew J. Grimm,et al.  Interpreting missense variants: comparing computational methods in human disease genes CDKN2A, MLH1, MSH2, MECP2, and tyrosinase (TYR) , 2007, Human mutation.

[21]  G. Guanti,et al.  In silico and in vivo splicing analysis of MLH1 and MSH2 missense mutations shows exon- and tissue-specific effects , 2006, BMC Genomics.

[22]  M. Genuardi,et al.  The use of microsatellite instability, immunohistochemistry and other variables in determining the clinical significance of MLH1 and MSH2 unclassified variants in Lynch syndrome. , 2006, Cancer biomarkers : section A of Disease markers.